• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Periostin promotes liver steatosis and hypertriglyceridemia through downregulation of PPARα.骨膜蛋白通过下调过氧化物酶体增殖物激活受体α(PPARα)促进肝脏脂肪变性和高甘油三酯血症。
J Clin Invest. 2014 Aug;124(8):3501-13. doi: 10.1172/JCI74438. Epub 2014 Jul 8.
2
Periostin: a new extracellular regulator of obesity-induced hepatosteatosis.骨膜蛋白:肥胖诱导的肝脂肪变性的一种新的细胞外调节因子。
Cell Metab. 2014 Oct 7;20(4):562-4. doi: 10.1016/j.cmet.2014.09.005.
3
Peroxisome proliferator-activated receptor α activation induces hepatic steatosis, suggesting an adverse effect.过氧化物酶体增殖物激活受体α的激活会诱发肝脂肪变性,提示存在不良影响。
PLoS One. 2014 Jun 13;9(6):e99245. doi: 10.1371/journal.pone.0099245. eCollection 2014.
4
The PPARβ/δ activator GW501516 prevents the down-regulation of AMPK caused by a high-fat diet in liver and amplifies the PGC-1α-Lipin 1-PPARα pathway leading to increased fatty acid oxidation.过氧化物酶体增殖物激活受体β/δ 激动剂 GW501516 可防止高脂肪饮食引起的肝脏中 AMPK 的下调,并放大 PGC-1α-脂肪酶 1-PPARα 通路,导致脂肪酸氧化增加。
Endocrinology. 2011 May;152(5):1848-59. doi: 10.1210/en.2010-1468. Epub 2011 Mar 1.
5
Reversal of diet-induced hepatic steatosis by peripheral CB1 receptor blockade in mice is p53/miRNA-22/SIRT1/PPARα dependent.阻断外周 CB1 受体可逆转小鼠饮食诱导的肝脂肪变性,其作用依赖于 p53/miRNA-22/SIRT1/PPARα。
Mol Metab. 2020 Dec;42:101087. doi: 10.1016/j.molmet.2020.101087. Epub 2020 Sep 26.
6
Aberrant miR199a-5p/caveolin1/PPARα axis in hepatic steatosis.肝脂肪变性中异常的miR199a - 5p/小窝蛋白1/过氧化物酶体增殖物激活受体α轴
J Mol Endocrinol. 2014 Dec;53(3):393-403. doi: 10.1530/JME-14-0127. Epub 2014 Oct 13.
7
Dietary capsaicin reduces obesity-induced insulin resistance and hepatic steatosis in obese mice fed a high-fat diet.膳食辣椒素可降低高脂肪饮食诱导肥胖小鼠的肥胖诱导性胰岛素抵抗和肝脂肪变性。
Obesity (Silver Spring). 2010 Apr;18(4):780-7. doi: 10.1038/oby.2009.301. Epub 2009 Oct 1.
8
Adipocyte-derived Periostin mediates glucocorticoid-induced hepatosteatosis in mice.脂肪细胞衍生的骨膜蛋白介导糖皮质激素诱导的小鼠肝脂肪变性。
Mol Metab. 2020 Jan;31:24-35. doi: 10.1016/j.molmet.2019.11.003. Epub 2019 Nov 9.
9
Steatogenesis in adult-onset type II citrullinemia is associated with down-regulation of PPARα.成人起病型II型瓜氨酸血症中的脂肪生成与过氧化物酶体增殖物激活受体α(PPARα)的下调有关。
Biochim Biophys Acta. 2015 Mar;1852(3):473-81. doi: 10.1016/j.bbadis.2014.12.011. Epub 2014 Dec 20.
10
Periostin antisense oligonucleotide prevents hepatic steatosis and fibrosis in a mouse model of non-alcoholic steatohepatitis.反义寡核苷酸对内质网应激诱导的肝星状细胞增殖和凋亡的影响及其机制
J Gastroenterol Hepatol. 2020 Dec;35(12):2140-2150. doi: 10.1111/jgh.15088. Epub 2020 May 13.

引用本文的文献

1
Upregulated FoxO1 promotes arrhythmogenesis in mice with heart failure and preserved ejection fraction.上调的FoxO1促进射血分数保留的心力衰竭小鼠的心律失常发生。
Nat Commun. 2025 Jan 30;16(1):1184. doi: 10.1038/s41467-025-56186-1.
2
Type 2 diabetes originated from non-alcoholic fatty liver disease.2型糖尿病起源于非酒精性脂肪性肝病。
Life Metab. 2023 Feb 21;2(1):load007. doi: 10.1093/lifemeta/load007. eCollection 2023 Feb.
3
A multi-omic landscape of steatosis-to-NASH progression.从肝脂肪变性到非酒精性脂肪性肝炎进展的多组学全景图。
Life Metab. 2022 Dec 1;1(3):242-257. doi: 10.1093/lifemeta/loac034. eCollection 2022 Dec.
4
Multiple Machine Learning Identifies Key Gene PHLDA1 Suppressing NAFLD Progression.多种机器学习方法鉴定出抑制非酒精性脂肪性肝病进展的关键基因PHLDA1。
Inflammation. 2024 Nov 4. doi: 10.1007/s10753-024-02164-6.
5
Osteokines in Nonalcoholic Fatty Liver Disease.非酒精性脂肪性肝病中的成骨细胞因子。
Curr Obes Rep. 2024 Dec;13(4):703-723. doi: 10.1007/s13679-024-00586-9. Epub 2024 Sep 3.
6
Relationship between polycystic ovary syndrome and high periostin level.多囊卵巢综合征与高骨膜蛋白水平的关系。
Rev Assoc Med Bras (1992). 2024 Jul 19;70(6):e20240138. doi: 10.1590/1806-9282.20240138. eCollection 2024.
7
Periostin-TGF-β feedforward loop contributes to tumour-stroma crosstalk in liver metastatic outgrowth of colorectal cancer.骨桥蛋白-TGF-β正反馈环路促进结直肠癌肝转移生长过程中的肿瘤-基质相互作用。
Br J Cancer. 2024 Feb;130(3):358-368. doi: 10.1038/s41416-023-02516-3. Epub 2023 Dec 14.
8
Association of Differentially Altered Liver Fibrosis with Deposition of TGFBi in Stabilin-Deficient Mice.稳定素缺陷型小鼠中差异改变的肝纤维化与 TGFBi 沉积的关联。
Int J Mol Sci. 2023 Jun 30;24(13):10969. doi: 10.3390/ijms241310969.
9
New insight of obesity-associated NAFLD: Dysregulated "crosstalk" between multi-organ and the liver?肥胖相关非酒精性脂肪性肝病的新见解:多器官与肝脏之间失调的“串扰”?
Genes Dis. 2022 Jan 28;10(3):799-812. doi: 10.1016/j.gendis.2021.12.013. eCollection 2023 May.
10
The Multiple Roles of Periostin in Non-Neoplastic Disease.骨膜蛋白在非肿瘤性疾病中的多重作用。
Cells. 2022 Dec 22;12(1):50. doi: 10.3390/cells12010050.

本文引用的文献

1
Production of monoclonal antibodies.单克隆抗体的制备。
Curr Protoc Immunol. 2013 Oct 1;102:2.5.1-2.5.29. doi: 10.1002/0471142735.im0205s102.
2
Hepatic steatosis exacerbated by endoplasmic reticulum stress-mediated downregulation of FXR in aging mice.衰老小鼠内质网应激介导的 FXR 下调加剧肝脂肪变性。
J Hepatol. 2014 Apr;60(4):847-54. doi: 10.1016/j.jhep.2013.12.003. Epub 2013 Dec 11.
3
Current role of fenofibrate in the prevention and management of non-alcoholic fatty liver disease.非诺贝特在非酒精性脂肪性肝病预防和管理中的当前作用。
World J Hepatol. 2013 Sep 27;5(9):470-8. doi: 10.4254/wjh.v5.i9.470.
4
Irisin is inversely associated with intrahepatic triglyceride contents in obese adults.鸢尾素与肥胖成年人肝内甘油三酯含量呈负相关。
J Hepatol. 2013 Sep;59(3):557-62. doi: 10.1016/j.jhep.2013.04.030. Epub 2013 May 9.
5
Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis.非酒精性脂肪性肝病向糖尿病、心血管疾病或肝硬化的进展。
Nat Rev Gastroenterol Hepatol. 2013 Jun;10(6):330-44. doi: 10.1038/nrgastro.2013.41. Epub 2013 Mar 19.
6
Activation of PPARα ameliorates hepatic insulin resistance and steatosis in high fructose-fed mice despite increased endoplasmic reticulum stress.过表达 PPARα 可改善高果糖喂养小鼠的肝胰岛素抵抗和脂肪变性,尽管内质网应激增加。
Diabetes. 2013 Jun;62(6):2095-105. doi: 10.2337/db12-1397. Epub 2013 Jan 24.
7
Yin Yang 1 promotes hepatic steatosis through repression of farnesoid X receptor in obese mice.阴阳 1 通过抑制肥胖小鼠法尼醇 X 受体促进肝脂肪变性。
Gut. 2014 Jan;63(1):170-8. doi: 10.1136/gutjnl-2012-303150. Epub 2013 Jan 24.
8
The role of hepatokines in metabolism.肝分泌物在代谢中的作用。
Nat Rev Endocrinol. 2013 Mar;9(3):144-52. doi: 10.1038/nrendo.2012.258. Epub 2013 Jan 22.
9
Misregulation of PPAR Functioning and Its Pathogenic Consequences Associated with Nonalcoholic Fatty Liver Disease in Human Obesity.PPAR 功能失调及其与人类肥胖相关的非酒精性脂肪性肝病的发病机制后果。
PPAR Res. 2012;2012:107434. doi: 10.1155/2012/107434. Epub 2012 Dec 9.
10
Periostin activates integrin α5β1 through a PI3K/AKT‑dependent pathway in invasion of cholangiocarcinoma.骨粘连蛋白通过 PI3K/AKT 依赖性途径激活整合素 α5β1 促进胆管癌细胞侵袭。
Int J Oncol. 2012 Sep;41(3):1110-8. doi: 10.3892/ijo.2012.1530. Epub 2012 Jun 25.

骨膜蛋白通过下调过氧化物酶体增殖物激活受体α(PPARα)促进肝脏脂肪变性和高甘油三酯血症。

Periostin promotes liver steatosis and hypertriglyceridemia through downregulation of PPARα.

作者信息

Lu Yan, Liu Xing, Jiao Yang, Xiong Xuelian, Wang E, Wang Xiaolin, Zhang Zhijian, Zhang Huijie, Pan Lingling, Guan Youfei, Cai Dongsheng, Ning Guang, Li Xiaoying

出版信息

J Clin Invest. 2014 Aug;124(8):3501-13. doi: 10.1172/JCI74438. Epub 2014 Jul 8.

DOI:10.1172/JCI74438
PMID:25003192
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4109546/
Abstract

Hepatosteatosis is characterized by an aberrant accumulation of triglycerides in the liver; however, the factors that drive obesity-induced fatty liver remain largely unknown. Here, we demonstrated that the secreted cell adhesion protein periostin is markedly upregulated in livers of obese rodents and humans. Notably, overexpression of periostin in the livers of WT mice promoted hepatic steatosis and hypertriglyceridemia. Conversely, both genetic ablation of periostin and administration of a periostin-neutralizing antibody dramatically improved hepatosteatosis and hypertriglyceridemia in obese mice. Overexpression of periostin resulted in reduced expression of peroxisome proliferator-activated receptor α (PPARα), a master regulator of fatty acid oxidation, and activation of the JNK signaling pathway. In mouse primary hepatocytes, inhibition of α6β4 integrin prevented activation of JNK and suppression of PPARα in response to periostin. Periostin-dependent activation of JNK resulted in activation of c-Jun, which prevented RORα binding and transactional activation at the Ppara promoter. Together, these results identify a periostin-dependent pathway that mediates obesity-induced hepatosteatosis.

摘要

肝脂肪变性的特征是肝脏中甘油三酯异常蓄积;然而,导致肥胖诱导型脂肪肝的因素在很大程度上仍不清楚。在此,我们证明分泌型细胞粘附蛋白骨膜蛋白在肥胖啮齿动物和人类的肝脏中显著上调。值得注意的是,在野生型小鼠肝脏中过表达骨膜蛋白会促进肝脂肪变性和高甘油三酯血症。相反,骨膜蛋白基因敲除和给予骨膜蛋白中和抗体均能显著改善肥胖小鼠的肝脂肪变性和高甘油三酯血症。骨膜蛋白过表达导致过氧化物酶体增殖物激活受体α(PPARα)表达降低,PPARα是脂肪酸氧化的主要调节因子,同时导致JNK信号通路激活。在小鼠原代肝细胞中,抑制α6β4整合素可防止JNK激活以及对骨膜蛋白反应时PPARα的抑制。骨膜蛋白依赖的JNK激活导致c-Jun激活,从而阻止RORα与Ppara启动子结合及转录激活。总之,这些结果确定了一条介导肥胖诱导型肝脂肪变性的骨膜蛋白依赖途径。